Bimuno TRAVELAID

 

The Clinical Challenge 

UK travellers account for around 23.7 million trips per annum to countries linked with Travellers’ Diarrhoea (TD)¹ and the percentage of UK travellers experiencing TD is reported at 30% to 50%². 

Symptoms include cramps, nausea, bloating in addition to diarrhoea, which as well as being distressing, can have a financial ‘cost’, eating into precious holiday or business time. 

Moreover, in approximately 15% of TD cases travellers experience vomiting, and up to 10% have diarrhoea accompanied by fever or bloody stools, or both³. 

More about Bimuno^® TRAVELAID 

Bimuno^® TRAVELAID is specially formulated with the specific needs of holidaymakers and business travellers in mind. It is the only product that is clinically proven to help prevent Travellers’ Diarrhoea and to help reduce its duration⁶. 

The Clinical Evidence 

Prevention of Travellers’ Diarrhoea: 

• 8 out of 10 subjects on Bimuno^® had a diarrhoea free holiday⁶
• Of those with diarrhoea symptoms, the duration was half compared to placebo⁶
• The duration and intensity of abdominal pain was significantly reduced compared to placebo⁶ 

Prevention of Pathogenic G.I. bacteria colonisation: 

• Bimuno strongly inhibited the attachment and colonisation of G.I. pathogens ~ enteropathogenic Escherichia coli4 and Salmonella Typhimurium^4,5. These pathogens are linked to most of the confirmed cases of Travellers’ Diarrhoea. 

Who can benefit from Bimuno^® TRAVELAID? 

It is ideal for those who are proactive about their travel health. Travellers’ Diarrhoea affects 30% to 50% of overseas travellers2. Travellers’ Diarrhoea can spoil a holiday or important business trip but now there is a clinically proven option that helps prevent TD. The following people can benefit from Bimuno^® TRAVELAID:
• Holidaymakers visiting countries at risk of TD, including families, retired couples and gap year travellers
• Business Travellers
• Sporting & similar organisations
             We were pleased to supply Bimuno^® to, and support the travel health of, a number of teams at the Delhi 2010 Commonwealth Games:
             • Team Wales
             • England Bowls Team
             • England Badminton Team
• Anyone who is proactive about Travel Health 

Recommending Bimuno^® TRAVELAID 

Bimuno^® TRAVELAID is classed as a food supplement and does not have any of the warnings and contra-indications associated with medicinal products. 

Although no adverse effects have been reported, it should be noted that Bimuno^® TRAVELAID contains small amounts of lactose (from milk). 

The product contains 30 chewable pastilles and the active ingredient is galacto-oligosaccharides equivalent to a daily dose of 2.76g. It is free from artificial colours, flavours and preservatives and is gluten free. The lactose content is 0.7g* per daily dose. Per daily dose it contains 26 kcal, 3.0g of sugar and 0.0g of fat. 

It is suitable for children aged 6 years and over and for adults. 

The dosage is three pastilles per day. For best results the three pastilles should be taken after breakfast. 

Bimuno^® TRAVELAID should be taken daily for seven days before travel and then daily for the duration of the holiday or business trip. 

Reference:
1. Office of Nat Stats: MQ6 Overseas Travel & Tourism Q4 2009, Table 26.
2. NHS.com: Travellers’ Diarrhoea.
3. Traveldoctor.co.uk:2009.
4. Tzortzis et al. J Nutr 2005;135:1726-1731.
5. Searle LEJ et al. Journal of Medical Microbiology 2009;58:37-48.
6. Drakoularakou A et al. European Journal of Clinical Nutrition 2010;64:146-152.